T1	Participants 0 31	Paracetamol and opioid pathways
T2	Participants 272 318	in humans with naloxone, the opioid antagonist
T3	Participants 320 456	After ethical approval, 12 healthy male volunteers were included in this randomized, controlled, double-blind, crossover, four-arm study
T4	Participants 1426 1442	human volunteers
